The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Rhythm Pharmaceuticals Inc shares valued at $248,639 were purchased by CHRISTOPHER PAUL GERMAN on Jul 09 ’25. At $65.14 per share, CHRISTOPHER PAUL GERMAN acquired 3,817 shares.
Also, PAMELA CRAMER purchased 15,572 shares, netting a total of over 1,014,360 in proceeds.
Before that, HUNTER SMITH had added 42,120 shares to its account. In a trade valued at $2,743,697, the Officer bought Rhythm Pharmaceuticals Inc shares for $65.14 each.
As published in their initiating research note from Leerink Partners on July 07, 2025, Rhythm Pharmaceuticals Inc [RYTM] has been an Outperform and the price target has been revised to $88. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early April. Earlier on January 02, 2025, Jefferies initiated its rating. Their recommendation was “a Buy” for RYTM stock.
Analyzing RYTM Stock Performance
On last trading session,, Rhythm Pharmaceuticals Inc [NASDAQ: RYTM] rose 36.63% to $89.0. The stock’s lowest price that day was $75.01, but it reached a high of $89.05 in the same session. During the last five days, there has been a surge of approximately 36.00%. Over the course of the year, Rhythm Pharmaceuticals Inc shares have jumped approximately 110.50%. Shares of the company reached a 52-week high of $89.05 on 07/09/25 and a 52-week low of $45.90 on 04/07/25.
Support And Resistance Levels for Rhythm Pharmaceuticals Inc (RYTM)
According to the 24-hour chart, there is a support level at 79.66, which, if violated, would cause prices to drop to 70.31. In the upper region, resistance lies at 93.70. The next price resistance is at 98.39. RSI (Relative Strength Index) is 82.22 on the 14-day chart, showing overbought technical sentiment.
Is Rhythm Pharmaceuticals Inc subject to short interest?
Stocks of Rhythm Pharmaceuticals Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.31 million shares to 4.76 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 5.07 million shares. A decline of -6.59% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.22 of the overall float, the days-to-cover ratio (short ratio) decline to 8.22.
Which companies own the most shares of Rhythm Pharmaceuticals Inc (RYTM)?
In terms of Rhythm Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 74 in the next 12 months, up nearly 13.6% from the previous closing price of $65.14. Analysts anticipate Rhythm Pharmaceuticals Inc stock to reach 78 by 2025, with the lowest price target being 70. In spite of this, 5 analysts ranked Rhythm Pharmaceuticals Inc stock as Buy at the end of 2025. On December 20, 2024, Oppenheimer assigned a price target of “an Outperform” to the stock and initiated coverage with a $76.
